RITLECITINIB for Vitiligo: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 10 adverse event reports in the FDA FAERS database where RITLECITINIB was used for Vitiligo.
Most Reported Side Effects for RITLECITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Drug ineffective | 259 | 18.0% | 0 | 0 |
| Therapeutic product effect incomplete | 122 | 8.5% | 0 | 0 |
| Condition aggravated | 85 | 5.9% | 0 | 0 |
| Off label use | 82 | 5.7% | 0 | 2 |
| Headache | 70 | 4.9% | 0 | 1 |
| Diarrhoea | 49 | 3.4% | 0 | 3 |
| Product dose omission issue | 45 | 3.1% | 0 | 0 |
| Alopecia | 44 | 3.1% | 0 | 0 |
| Fatigue | 36 | 2.5% | 0 | 0 |
| Urticaria | 36 | 2.5% | 0 | 1 |
| Acne | 35 | 2.4% | 0 | 0 |
| Pruritus | 34 | 2.4% | 0 | 0 |
| Blood creatine phosphokinase increased | 29 | 2.0% | 0 | 1 |
| Nausea | 29 | 2.0% | 0 | 1 |
| Rash | 29 | 2.0% | 0 | 1 |
Other Indications for RITLECITINIB
Alopecia areata (670)
Alopecia (147)
Alopecia totalis (43)
Alopecia universalis (38)
Alopecia scarring (10)
Lichen planopilaris (8)
Product used for unknown indication (8)
Androgenetic alopecia (6)
Other Drugs Used for Vitiligo
RUXOLITINIB (1,053)
TACROLIMUS (156)
TOFACITINIB (71)
PIMECROLIMUS (20)
CRISABOROLE (19)
PROTOPIC (17)
TRIAMCINOLONE ACETONIDE (17)
DUPILUMAB (14)
CLOBETASOL (13)
UPADACITINIB (13)